← Open Payments lookup

AMANDA SHULSKI: Open Payments

NPI 1700513025 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,846 in 167 payments from 19 companies in 2025. Trend: 2023 $92 · 2024 $490 · 2025 $3,846

Food & beverage: $3,846
CompanyPaymentsAmount
ABBVIE INC.33$695
Madrigal Pharmaceuticals23$578
Janssen Biotech, Inc.25$541
Ardelyx, Inc.19$495
Janssen Scientific Affairs, LLC3$369
QOL Medical, LLC15$305
Salix Pharmaceuticals, a division of Bausch Health US, LLC15$239
Aimmune Therapeutics, Inc.11$169
Lilly USA, LLC4$79
Braintree Laboratories, Inc.3$72

Products named: TREMFYA, REZDIFFRA, IBSRELA, Sucraid, RINVOQ, XIFAXAN, ZENPEP, CREON.

Industry payments across PA — which companies pay providers there.